Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have gotten a nod from analysts at Goldman Sachs Group Inc. The analysts initiated coverage of six large-cap pharmaceutical stocks on Thursday, saying “innovation …